Swiss drug maker Novartis AG (NVS) plans to sell 13.5 billion Swiss francs stake in its Roche (ROG.S) and has already hired banks to support the selling process, Sonntagszeitung reported.
The Swiss paper said that Novartis plans to sell the stake in order book process, having banks collect purchase offers within a predefined price range from selected investors, weekly.
For comments and feedback: editorial@rttnews.com